Wick et al. demonstrated that an overexpression of the anti-apoptotic proteins Bcl-2 or Bcl-xL in GBM cell lines increases migration and tumoral invasion through apoptosis resistance [58,59,60]. This evidence concerns the gene BCL2 and glioblastoma.